Engagement of β-arrestin by transactivated insulin-like growth factor receptor is needed for V2 vasopressin receptor-stimulated ERK1/2 activation. Proceedings of the National Academy of Sciences of the United States of America 109:E1028-E1037

Institut de Recherche en Immunologie et Cancérologie, Département de Biochimie and Groupe de Recherche Universitaire sur le Médicament, Université de Montréal, Montréal, QC, Canada H3C 3J7.
Proceedings of the National Academy of Sciences (Impact Factor: 9.67). 04/2012; 109(17):E1028-37. DOI: 10.1073/pnas.1112422109
Source: PubMed


G protein-coupled receptors (GPCRs) have been shown to activate the mitogen-activated protein kinases, ERK1/2, through both G protein-dependent and -independent mechanisms. Here, we describe a G protein-independent mechanism that unravels an unanticipated role for β-arrestins. Stimulation of the V2 vasopressin receptor (V2R) in cultured cells or in vivo in rat kidney medullar collecting ducts led to the activation of ERK1/2 through the metalloproteinase-mediated shedding of a factor activating the insulin-like growth factor receptor (IGFR). This process was found to be both Src- and β-arrestin-dependent. Whereas Src was found to act upstream of the metalloproteinase activation and be required for the release of the IGFR-activating factor, β-arrestins were found to act downstream of the IGFR transactivation. Unexpectedly, the engagement of β-arrestins by the IGFR but not by the V2R was needed to promote the vasopressin-stimulated ERK1/2 activation, indicating that a pool of β-arrestins distinct from those β-arrestins recruited to the V2R acts downstream of the receptor tyrosine kinase to activate ERK1/2. Such a dual site of action for β-arrestins helps explain the pleiotropic actions of this scaffolding protein. Given the role that V2R-stimulated ERK1/2 plays in kidney cell proliferation, this transactivation mechanism may have important implications for renal pathophysiology. Still, the role of β-arrestins downstream of a transactivation event is not limited to the V2R, because we observed a similar involvement for an unrelated GPCR (the platelet-activating factor receptor), indicating that it may be a general mechanism shared among GPCRs.

Download full-text


Available from: Maïthé Corbani, Jul 25, 2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: β-Arrestins 1 and 2 are ubiquitously expressed proteins that play a dual role in G protein-coupled receptor (GPCR) signaling. On the one hand, arrestins are central to the termination of G protein-mediated receptor signaling and subsequent clathrin-dependent internalization. On the other hand, these proteins act as molecular scaffolds for G protein-independent GPCR signaling. This review provides an overview of how these dual functions of arrestins contribute to the biological outcomes associated to the activation of different brain GPCR. It also explores recent evidence suggesting how the dual function of arrestins can lead to the development of more selective pharmacological approaches for the treatment of central nervous system disorders such as chronic pain, bipolar disorder, major depression, and schizophrenia. Development of such approaches may lead to new drugs having better clinical efficacy and lesser side effects.
    No preview · Article · Jun 2013 · Progress in molecular biology and translational science
  • [Show abstract] [Hide abstract]
    ABSTRACT: Multiple signaling processes are characterized by bursts of calcium ions that moves to specific locations for optimal activation of cell activity. Intracellular calcium regulates numerous protein functions in tiny cellular domains ( V1.2 channels form signaling clusters in plasmalemmal nanodomains. Fluorescence microscopy is aimed at imaging in real time communication within and between cells. Calcium fluxes through Ca\({}^{++}\) channels and gap junctions can be imaged once constitutive proteins (e.g., connexin) have been tagged with tetracysteines [1429].
    No preview · Chapter · Jan 2013
  • [Show abstract] [Hide abstract]
    ABSTRACT: Numerous protein serine/threonine kinases operate in signal transduction, either as initiating nodes, such as receptor (RSTK; Vol. 3 – Chap. 8. Receptor Kinases), or as intermediate nodes of signaling cascades, non-receptor (intracellular; NRSTK) protein Ser/Thr kinases. Typically, second messengers activate protein Ser/Thr kinases, whereas extracellular signals stimulate protein Tyr kinases (Chap. 4). For example, IκB kinases (IKK) of IκB inhibitors of nuclear factor-κB are serine kinases (Sect. 10.9.1).
    No preview · Chapter · Jan 2013
Show more